Clicky

Tuesday, November 3, 2026

Tech

Technology companies and products

Shwed Gil Reports Share Transactions for Check Point Software

Shwed Gil's recent share transactions for Check Point Software Technologies highlight ownership changes in the software services sector.

Halozyme CEO Torley Helen Reports Multiple Stock Transactions

Torley Helen, President and CEO of Halozyme Therapeutics, disclosed multiple stock transactions in a recent SEC filing, signaling significant ownership changes.

Kurtz George Sells 9,000 Shares of CrowdStrike Stock

Kurtz George, President and CEO of CrowdStrike, sold 9,000 shares under a 10b5-1 plan, reflecting ongoing activities in the tech industry.

Ullal Jayshree Sells Shares in Arista Networks Transaction

Ullal Jayshree, CEO of Arista Networks, sold shares under a trading plan, reflecting strategic asset management in the computer communications equipment sector.

Arista Networks CFO Breithaupt Sells 1,224 Shares

Chantelle Breithaupt, CFO of Arista Networks, sold 1,224 shares of common stock as part of a pre-established trading plan, reducing her holdings to 68,697 shares.

Apple's Newstead Sells 2,399 Shares Under Trading Plan

Jennifer Newstead, SVP and General Counsel at Apple, sells 2,399 shares as part of a planned trading strategy, reflecting ongoing executive stock management.

Eric Singer Reports Stock Transactions at Immersion Corp

Eric Singer, President and CEO of Immersion Corp, reports multiple stock transactions, reflecting confidence in the company's future and performance.

Immersion Corp's Chief Strategy Officer Acquires Shares

William C. Martin, Chief Strategy Officer at Immersion Corp, acquires 17,217 shares through a restricted stock grant, reflecting leadership incentives.

Arqit Quantum director Garth Ritchie disposes of shares

Arqit Quantum's Garth Ritchie reports disposal of 118 shares, reflecting executive changes that could impact investor confidence in the prepackaged software sector.

Wasch Childress Frederick Acquires 17,217 Shares of Immersion

Wasch Childress Frederick increases his stake in Immersion Corp by acquiring 17,217 shares, totaling 105,130 shares owned.

Nilan Nicholas William sells 493 shares of Arqit Quantum

Nilan Nicholas William sold 493 shares of Arqit Quantum Inc. on October 6, reflecting changes in executive ownership within the company.

Arqit CEO Andrew Leaver Sells Shares in Recent Transaction

Andrew Leaver, CEO of Arqit Quantum Inc., sells 2,398 shares, reflecting active management engagement in the prepackaged software industry.

Willcocks Patrick reports share sale at Arqit Quantum Inc.

Patrick Willcocks, General Counsel at Arqit Quantum Inc., disclosed a sale of 555 shares in a recent SEC filing, indicating ongoing investment activity.

Wilder Ben Simon Sells 218 Shares of Arqit Quantum Inc.

Wilder Ben Simon, COO of Arqit Quantum, sold 218 shares on October 6, 2026, reflecting ongoing insider trading activity in the prepackaged software sector.

Martins Fernando Matt Borges Increases Stake in CI&T Inc

Martins Fernando Matt Borges has reported significant stock purchases in CI&T Inc, raising his ownership in the company.

Stat Lauren Elaina Friedman Sells 5,026 Shares of Palantir

Stat Lauren Elaina Friedman reports sale of 5,026 shares of Palantir Technologies, reflecting ongoing activity in the prepackaged software services sector.

Palantir Technologies Officer Sells 18,000 Shares of Stock

Taylor Ryan D., Chief Revenue Officer at Palantir, sold 18,000 shares of Class A Common Stock, signaling ongoing stock management strategies.

CFO Catinazzo Thomas sells shares of Relay Therapeutics

CFO Catinazzo Thomas sells 17,511 shares of Relay Therapeutics, reflecting ongoing financial strategies in the biotechnology sector.

Skydance Corp reports executive stock unit transaction

Skydance Corp reports a significant transaction involving restricted stock units, reflecting trends in executive compensation in the television broadcasting industry.

Relay Therapeutics CEO Sanjiv Patel Sells 48,199 Shares

Sanjiv Patel, CEO of Relay Therapeutics, sold 48,199 shares of stock, reflecting ongoing stock management in the biotech industry.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →